Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase

被引：54

作者：

Sudbeck, EA

Mao, C

Vig, R

Venkatachalam, TK

Tuel-Ahlgren, L

Uckun, FM ^{[1
]}

机构：

[1] Hughes Inst, Drug Discovery Program, St Paul, MN 55113 USA

[2] Hughes Inst, Dept Chem, St Paul, MN 55113 USA

[3] Hughes Inst, Dept Biol Struct, St Paul, MN 55113 USA

[4] Hughes Inst, Dept Virol, St Paul, MN 55113 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 12期

关键词：

D O I：

10.1128/AAC.42.12.3225

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Two highly potent dihydroalkoxybenzyloxopyrimidine (DABO) derivatives targeting the nonnucleoside inhibitor (NNI) binding site of human immunodeficiency virus (HIV) reverse transcriptase (RT) have been designed based on the structure of the NNI binding pocket and tested for anti-HIV activity. Our lead DABO derivative, 5-isopropyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-one, elicited potent inhibitory activity against purified recombinant HIV RT and abrogated HIV replication in peripheral blood mononuclear cells at nanomolar concentrations (50% inhibitory concentration, <1 nM) but showed no detectable cytotoxicity at concentrations as high as 100 mu M.

引用

页码：3225 / 3233

页数：9

共 49 条

[1] THE PETT SERIES, A NEW CLASS OF POTENT NONNUCLEOSIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].

AHGREN, C ;

BACKRO, K ;

BELL, FW ;

CANTRELL, AS ;

CLEMENS, M ;

COLACINO, JM ;

DEETER, JB ;

ENGELHARDT, JA ;

HOGBERG, M ;

JASKUNAS, SR ;

JOHANSSON, NG ;

JORDAN, CL ;

KASHER, JS ;

KINNICK, MD ;

LIND, P ;

LOPEZ, C ;

MORIN, JM ;

MUESING, MA ;

NOREEN, R ;

OBERG, B ;

PAGET, CJ ;

PALKOWITZ, JA ;

PARRISH, CA ;

PRANC, P ;

RIPPY, MK ;

RYDERGARD, C ;

SAHLBERG, C ;

SWANSON, S ;

TERNANSKY, RJ ;

UNGE, T ;

VASILEFF, RT ;

VRANG, L ;

WEST, SJ ;

ZHANG, H ;

XHOU, XX .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1329-1335

[2] HIGHLY POTENT AND SELECTIVE-INHIBITION OF HIV-1 REPLICATION BY 6-PHENYLTHIOURACIL DERIVATIVES [J].

BABA, M ;

SHIGETA, S ;

TANAKA, H ;

MIYASAKA, T ;

UBASAWA, M ;

UMEZU, K ;

WALKER, RT ;

PAUWELS, R ;

DECLERCQ, E .

ANTIVIRAL RESEARCH, 1992, 17 (04) :245-264

[3]

Balzarini J, 1995, Verh K Acad Geneeskd Belg, V57, P575

[4] 2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-3'-SPIRO-5''-(4''-AMINO-1',2''-OXATHIOLE-2'',2''-DIOXIDE)PYRIMIDINE (TSAO) NUCLEOSIDE ANALOGS - HIGHLY SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAT ARE TARGETED AT THE VIRAL REVERSE-TRANSCRIPTASE [J].

BALZARINI, J ;

PEREZPEREZ, MJ ;

SANFELIX, A ;

SCHOLS, D ;

PERNO, CF ;

VANDAMME, AM ;

CAMARASA, MJ ;

DECLERCQ, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4392-4396

[5] PHENETHYLTHIAZOLETHIOUREA (PETT) COMPOUNDS, A NEW CLASS OF HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS .1. SYNTHESIS AND BASIC STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF PETT ANALOGS [J].

BELL, FW ;

CANTRELL, AS ;

HOGBERG, M ;

JASKUNAS, SR ;

JOHANSSON, NG ;

JORDAN, CL ;

KINNICK, MD ;

LIND, P ;

MORIN, JM ;

NOREEN, R ;

OBERG, B ;

PALKOWITZ, JA ;

PARRISH, CA ;

PRANC, P ;

SAHLBERG, C ;

TERNANSKY, RJ ;

VASILEFF, RT ;

VRANG, L ;

WEST, SJ ;

ZHANG, H ;

ZHOU, XX .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4929-4936

[6] LUDI - RULE-BASED AUTOMATIC DESIGN OF NEW SUBSTITUENTS FOR ENZYME-INHIBITOR LEADS [J].

BOHM, HJ .

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (06) :593-606

[7] THE DEVELOPMENT OF A SIMPLE EMPIRICAL SCORING FUNCTION TO ESTIMATE THE BINDING CONSTANT FOR A PROTEIN LIGAND COMPLEX OF KNOWN 3-DIMENSIONAL STRUCTURE [J].

BOHM, HJ .

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1994, 8 (03) :243-256

[8] SCINTILLATION PROXIMITY ASSAY [J].

BOSWORTH, N ;

TOWERS, P .

NATURE, 1989, 341 (6238) :167-168

[9] Highly potent oxathiin carboxanilide derivatives with efficacy against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus isolates [J].

Buckheit, RW ;

Snow, MJ ;

FliakasBoltz, V ;

Kinjerski, TL ;

Russell, JD ;

Pallansch, LA ;

Brouwer, WG ;

Yang, SS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) :831-837

[10] Efficacy, pharmacokinetics, and in vivo antiviral activity of UC781, a highly potent, orally bioavailable nonnucleoside reverse transcriptase inhibitor of HIV type 1 [J].

Buckheit, RW ;

Hollingshead, M ;

Sinson, S ;

FliakasBoltz, V ;

Pallansch, LA ;

Roberson, J ;

Decker, W ;

Elder, C ;

Borgel, S ;

Bonomi, C ;

Shores, R ;

Siford, T ;

Malspeis, L ;

Bader, JP .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (09) :789-796

← 1 2 3 4 5 →